A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma

Cancer Genetics and Cytogenetics

Volumn 151, Issue 1, 2004, Pages 73-77

  Ho, Richard H ^a   Johnson, Joyce ^a   Dev, Vaithilingam G ^b   Whitlock, James A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Genetics Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ARTICLE; CASE REPORT; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 2; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 20; DNA-BINDING PROTEINS; FEMALE; HUMANS; KARYOTYPING; PAIRED BOX TRANSCRIPTION FACTORS; RHABDOMYOSARCOMA, EMBRYONAL; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 2342475764     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.08.023     Document Type: Article

References (32)

1. Pappo A.S., Shapiro D.N., Crist W.M., Maurer H.M. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol. 13:1995;2123-2139
2. Wexler L.H., Helman L.J. Rhabdomyosarcoma and the undifferentiated sarcomas. Pizzo P.A., Poplack D.G. Principles and practice of pediatric oncology. 1997;799-830 Lippincott-Raven, Philadelphia
3. Crist W.M., Anderson J.R., Meza J.L., Fryer C., Raney R.B., Ruymann F.B., Breneman J., Qualman S.J., Wiener E., Wharam M., Lobe T., Webber B., Maurer H.M., Donaldson S.S. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 19:2001;3091-3102
4. Raney R.B., Anderson J.R., Barr F.G., Donaldson S.S., Pappo A.S., Qualman S.J., Wiener E.S., Maurer H.M., Crist W.M. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V. Am J Pediatr Hematol Oncol. 23:2001;215-220
5. Seidal T., Mark J., Hagmar B., Angervall L. Alveolar rhabdomyosarcoma: a cytogenetic and correlated cytological and histological study. Acta Pathol Microbiol Immunol Scand [A]. 90:1982;345-354
6. Mitelman F. Catalog of chromosome aberrations in cancer. 1994;Wiley-Liss, New York
7. Scrable H., Witte D., Shimada H., Seemayer T., Sheng W.W., Soukup S., Koufos A., Houghton P., Lampkin B., Cavenee W. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer. 1:1989;23-35
8. Koufos A., Hansen M.F., Copeland N.G., Jenkins N.A., Lampkin B.C., Cavenee W.K. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature. 316:1985;330-334
9. Koufos A., Hansen M.F., Lampkin B.C., Workman M.L., Copeland N.G., Jenkins N.A., Cavenee W.K. Loss of alleles at loci on human chromosome 11 during genesis of Wilms tumour. Nature. 309:1984;170-172
10. Arndt C.A., Nascimento A.G., Schroeder G., Schomberg P.J., Neglia J.P., Sencer S.F., Silberman T.L., Moertel C.L., Tillisch J.K., Miser J.S. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide. Eur J Cancer. 34:1998;1224-1229
11. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher F.J. III, Emanuel B.S., Rovera G., Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet. 5:1993;230-235
12. Shapiro D.N., Sublett J.E., Li B., Downing J.R., Naeve C.W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53:1993;5108-5112
13. Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., Barr F.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54:1994;2869-2872
14. Goulding M.D., Chalepakis G., Deutsch U., Erselius J.R., Gruss P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10:1991;1135-1147
15. Fredericks W.J., Galili N., Mukhopadhyay S., Rovera G., Bennicelli J., Barr F.G., Rauscher F.J. III. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol Cell Biol. 15:1995;1522-1535
16. Polito P., Dal Cin P., Sciot R., Brock P., Van Eyken P., Van den Berghe H. Embryonal rhabdomyosarcoma with only numerical chromosome changes. Case report and review of the literature. Cancer Genet Cytogenet. 109:1999;161-165
17. Anderson J., Gordon A., Pritchard-Jones K., Shipley J. Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer. 26:1999;275-285
18. Weber-Hall S., Anderson J., McManus A., Abe S., Nojima T., Pinkerton R., Pritchard-Jones K., Shipley J. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res. 56:1996;3220-3224
19. Barr F.G. Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol. 19:1997;483-491
20. Loh W.E. Jr., Scrable H.J., Livanos E., Arboleda M.J., Cavenee W.K., Oshimura M., Weissman B.E. Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc Natl Acad Sci USA. 89:1992;1755-1759
21. Koi M., Johnson L.A., Kalikin L.M., Little P.F., Nakamura Y., Feinberg A.P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science. 260:1993;361-364
22. Rao V.V., Schnittger S., Hansmann I. Chromosomal localization of the human proliferating cell nuclear antigen (PCNA) gene to or close to 20p12 by in situ hybridization. Cytogenet Cell Genet. 56:1991;169-170
23. Paunesku T., Mittal S., Protic M., Oryhon J., Korolev S.V., Joachimiak A., Woloschak G.E. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol. 77:2001;1007-1021
24. Morris G.F., Mathews M.B. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem. 264:1989;13856-13864
25. Tokuc G., Dogan O., Ayan I., Kebudi R., Dogan S., Demiryont M., Camlica H. Prognostic value of proliferating cell nuclear antigen immunostaining in pediatric rhabdomyosarcomas. Acta Paediatr Jpn. 40:1998;573-579
26. Woods A.L., Hall P.A., Shepherd N.A., Hanby A.M., Waseem N.H., Lane D.P., Levison D.A. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology. 19:1991;21-27
27. Yu C.C., Fletcher C.D., Newman P.L., Goodlad J.R., Burton J.C., Levison D.A. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol. 166:1992;147-152
28. Kitamoto M., Nakanishi T., Kira S., Kawaguchi M., Nakashio R., Suemori S., Kajiyama G., Asahara T., Dohi K. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer. 72:1993;1859-1865
29. Klemi P.J., Alanen K., Jalkanen S., Joensuu H. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin lymphoma. Br J Cancer. 66:1992;739-743
30. Oda Y., Hashimoto H., Takeshita S., Tsuneyoshi M. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer. 72:1993;478-485
31. Shimizu T., Usuda N., Yamanda T., Sugenoya A., Iida F. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer. 71:1993;2807-2812
32. Fontanini G., Macchiarini P., Pepe S., Ruggiero A., Hardin M., Bigini D., Vignati S., Pingitore R., Angeletti C.A. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer. 70:1992;1520-1527